Naomi Luban, MD Hematologist, Laboratory Medicine Specialist

Bio

Biography

Naomi L. Luban, MD, is Chair of the IRB, the Medical Director of the Office of Protection of Human Subjects at Children's National Health System, Director of the Blood Donor Center, Associate Program Director for the General Clinical Research Center, and Vice Chair for Faculty Affairs at Children's National. She has been an attending physician at Children’s National for more than 30 years.

Dr. Luban has published more than 140 peer-reviewed journal articles and more than 40 book chapters. She has edited seven texts in pediatric transfusion medicine and is an editorial board member for Transfusion and the American Journal of Hematology. In addition, Dr. Luban is a peer-reviewer for Transfusion, JAMA, Immunohematology, The Journal of Pediatrics, and Pediatric Blood and Cancer, among others.

Currently, Dr. Luban is a Fellow of the American Academy of Pediatrics, the Chair of the Committee on Blood Disorders in Childhood of the American Society of Hematology, and a member of the Board of Trustees of the American Society of Pediatric Hematology/Oncology.

Her clinical interests are focused in inherited platelet disorders and hemophilia.

Dr. Luban lives in Maryland and has two children.

Education & Training

Education & Training

  • Fellowship Program, Pediatric Hematology/Oncology, 1976
    New York Hospital Cornell Medical Center
  • Residency Program, Pediatrics, 1974
    Children's National Medical Center
  • Internship Program, Pediatrics, 1973
    Children's National Medical Center
Patient Stories

Patient Stories: Naomi Luban

Patient story

Staci's Story

"As a parent/caretaker, you want to fight with every ounce of fight that you have. It's normal and necessary to help you feel like you are fighting right along with your precious baby."

News

News

Naomi Luban, MD, Discusses Importance of Blood Transfusion Protocols

Naomi L.C. Luban, MD, Chief of Transfusion Medicine at Children’s National Health System, discusses with AABB News the importance of healthcare institutions establishing standard protocols and strategies to minimize the risk of complications for pediatric patients needing blood transfusions.

Research & Publications

Research & Publications

Blood component therapy

(2008) Pediatric Clinics of North America

Blood transfusions in children a multiinstitutional analysis of practices and complications

(2008) Transfusion

Management of anemia in the newborn

(2008) Early Human Development

National Sickle Cell Disease Program

(2007) Selection of Blood and Blood Products. Best Practices in Transfusion Medicine for Patients with Sickle Cell Disease

rs660 polymorphism in Ro52 SSA1 TRIM21 is a marker for agedependent tolerance induction and efficiency of alloimmunization in sickle cell disease

(2009) Molecular Immunology

Sickle cell disease summit from clinical and research disparity to action

(2009) American Journal of Hematology

St Jude Childrens Research Hospital

(2008) Transfusion Issues for SWITCH: Stroke with transfusions changing to hydroxyurea.

The American Public Health Association Annual Meeting

(2007) Sickle Cell Disease: From Bench to Bedside to Prevention

Too much too little too soon too late Transfusion and longterm survival in children

(2008) Transfusion

View publications on PubMed

Invest in future cures for some of life's most devastating diseases

See other ways to give

Keep in touch with Children's National by signing up for our newsletters.

Sign up now

Zahara's Story

Patient story

"In the midst of every situation remember that there is no situation that you will face that you (along with your support team) are not well-equipped to handle."

Read More of Zahara's Story